Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-208.82M
↓ 62% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-128.69M
Historical baseline
PeriodValueYoY Change
TTM$-208.82M-14.2%
2024$-182.94M-12.0%
2023$-163.28M-42.1%
2022$-114.90M-52.3%
2021$-75.42M-181.8%
2020$-26.76M-